Table 1.
Conditions/Disorders | Participants (Number) | Tissue/Cells & Collection Method | Observations | Reference | |
---|---|---|---|---|---|
Circadian Markers | Results | ||||
Day and night shifts | Female diurnal workers (10) and shift workers (10) | Keratinocytes and dermal papilla stem cells isolated from HFs | PER1 BMAL1 | Protein expression increased in the deregulated group | [68] |
Rotating shift workers (6) | Scalp HFs; 3 h intervals |
PER2
PER3 NR1D1 NR1D2 |
Phase: ~2 h delay | [12] | |
Male daytime workers (11), nurses and doctors (10), and factory workers (11) |
Beard HFs; 4 h intervals |
PER3 | Mesor: decrease after consecutive night shifts Amplitude: fewer workers with significant 24 h rhythms after night shifts Phase: n.s. |
[69] | |
NR1D1 | Mesor: n.s. Amplitude: n.s. Phase: n.s. |
||||
NR1D2 | Mesor: decrease after one night shift Amplitude: fewer workers with significant 24 h rhythms after night shifts Phase: n.s. |
||||
Female shift (23) and daytime nurses (25) | Pubic HFs; Five time points |
PER2 | Shift nurses exhibited lower circadian variations than did daytime nurses | [70] | |
Sleep disorders | Healthy male participants (16) and male patients with the delayed sleep–wake phase disorder (18) | Beard HFs; 4 h intervals |
PER3 | Amplitude: n.s. Phase: delayed in the group with delayed sleep-wake phase disorder |
[71] |
NR1D1 | Amplitude: n.s. Phase: n.s. |
||||
NR1D2 | Amplitude: n.s. Phase: n.s. |
||||
Latent circadian rhythm sleep–wake disorders (24) | Scalp HFs; 8 h intervals |
PER3 | Peak time of PER3 expression and GUw are positively correlated | [72] | |
Physical activity | Adult males (20) | Facial HFs; 4 h intervals |
PER3 | Amplitude: higher in the active group | [73] |
NR1D1 | Amplitude: n.s. | ||||
NR1D2 | Amplitude: n.s. | ||||
Healthy male (1) | Facial HFs; 4 h intervals |
PER3
NR1D1 NR1D2 |
Mesor: n.s. Amplitude: n.s. Phase: 2–4 h delay during habitual nighttime training |
[74] | |
Chronotype | Young men (24) | Facial HFs; 4 h intervals |
PER3
NR1D1 NR1D2 |
Peak time of PER3 expression was delayed in the eveningness group; change in the peak time of NR1D1 and PER3 expression from the Friday to Monday trial was high in the eveningness group |
[75] |
Decision-making | Extreme morning (16) and evening chronotype (8) | Plucked hairs; 8 h intervals |
PER3
NR1D2 |
3 h phase differences between morning and evening chronotypes | [76] |
Energy metabolism | Total parenteral nutrition (TPN) (78) and non-TPN aged subjects (6) | Scalp HFs; 6 h intervals |
PER3 | Peak time of PER3 relative to wake-up time was delayed in TPN patients | [77] |
Age-related diseases | Nondementia elderly subjects (10) and old–old dementia patients (5) | Scalp HFs; 6 h intervals |
PER3
NR1D1 NR1D2 |
Peripheral circadian phases in dementia subjects were within normal range | [78] |
Parkinson’s disease patients (17) | Scalp HFs; 6 h intervals |
PER3
NR1D1 NR1D2 |
Phase: delayed after bright light therapy | [79] |
Abbreviations: HFs—hair follicles; n.s.—nonsignificant; GUw—local time of getting out of bed on working or school days. Gene names are italicized and protein names are not.